Studies have shown that active fund managers routinely underperform the S&P500 index*​

TG Therapeutics, Inc. (NASDAQ: TGTX)

TGTX Stock Predictions and Ratings

WSX Rating:
BUY
WSX Forecast (1yr):
5.80%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
33.10%

TGTX Stock Analysis

TGTX PE Ratio: 14

TGTX PEG Ratio: Not Available

TGTX Forward EPS Growth (12 month): 0.00%

TGTX PS Ratio: 8.8

TGTX PSG Ratio: Not Available

TGTX Forward Revenue Growth (12 month): 0.00%

TGTX Articles

No data was found